Business Context and Reporting Period
This Form 8-K is a current report filed by 180 Life Sciences Corp. (not Forum Markets Inc.) on December 14, 2021, regarding events occurring on December 10, 2021. The filing details the results of the Company's 2021 Annual Meeting of Stockholders, which was conducted via live audio webcast. The Company is an emerging growth company incorporated in Delaware.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. There are no disclosures regarding revenue, profit, cash flow, margins, debt, or liquidity in this document.
Material Changes and Voting Results
The filing reports the outcome of two proposals voted on by stockholders. A quorum was established with 19,440,009.79 shares (57.1% of total outstanding voting shares) present or represented by proxy.
- Proposal 1: Election of Directors
- All four Class I director nominees were elected by a plurality of votes cast.
- Lawrence Steinman, M.D.: 10,152,898.79 For / 76,430.00 Against
- James N. Woody, M.D., Ph.D.: 10,154,780.79 For / 74,548.00 Against
- Russell T. Ray, MBA: 10,157,951.79 For / 71,377.00 Against
- Francis Knuettel II, MBA: 10,153,374.79 For / 75,954.00 Against
- Each director will serve a two-year term.
- Proposal 2: Ratification of Independent Auditors
- Stockholders approved the appointment of Marcum LLP as the independent auditors for the fiscal year ending December 31, 2021.
- Votes For: 19,320,928.79
- Votes Against: 13,294.00
- Abstentions: 105,787.00
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly reports the administrative results of the annual meeting.
Investor Verification Checklist
- Verify the correct registrant name is 180 Life Sciences Corp. (Ticker: ATNF), as the request metadata incorrectly listed "Forum Markets Inc."
- Confirm the appointment of the four new directors and their two-year terms.
- Review the Definitive Proxy Statement on Schedule 14A (filed October 19, 2021) for detailed biographies of the directors and further context on the auditor ratification.
- Note that this document provides no financial data; refer to the most recent 10-K or 10-Q for financial metrics.